• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Chain Bridge I filed SEC Form 8-K: Other Events

    9/13/24 5:25:15 PM ET
    $CBRG
    Blank Checks
    Finance
    Get the next $CBRG alert in real time by email
    false 0001845149 0001845149 2024-09-13 2024-09-13 0001845149 CBRGU:UnitseachconsistingofoneClassAordinaryshareandonehalfofoneredeemableWarranttoacquireoneClassAordinaryshareMember 2024-09-13 2024-09-13 0001845149 us-gaap:CommonClassAMember 2024-09-13 2024-09-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): September 13, 2024

     

    Chain Bridge I

    (Exact name of registrant as specified in its charter)

     

    Cayman Islands   001-41047   98-1578955

    (State or other jurisdiction of
    incorporation or organization)

      (Commission File Number)  

    (I.R.S. Employer
    Identification Number)

     

    8 The Green #17538
    Dover, DE

      19901
    (Address of principal executive offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: (202) 656-4257

     

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading
    Symbol(s)
      Name of each exchange on
    which
    registered
    Units, each consisting of one Class A ordinary share and one-half of one redeemable Warrant to acquire one Class A ordinary share   CBRGU   The Nasdaq Capital Market
    Class A ordinary shares, par value $0.0001 per share   CBRG   The Nasdaq Capital Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

     

    Emerging growth company  x

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

     

     

     

     

     

     

    Item 8.01Other Events.

     

    As previously disclosed, on June 20, 2024, Chain Bridge I (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company no longer complied with the Nasdaq Capital Market continued listing criteria set forth in Listing Rule 5550(a)(3), which requires the Company to maintain a minimum of 300 public holders (the “Public Shareholder Rule”).

     

    On September 13, 2024, the Company was notified by Nasdaq that the Company had regained compliance with Public Shareholder Rule.

     

     

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Dated: September 13, 2024

     

      CHAIN BRIDGE I
       
      By: /s/ Andrew Cohen
      Name: Andrew Cohen
      Title: Chief Executive Officer

     

     

     

    Get the next $CBRG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CBRG

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CBRG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Kucharchuk Andrew Albert

    3 - Chain Bridge I (0001845149) (Issuer)

    4/5/24 4:19:27 PM ET
    $CBRG
    Blank Checks
    Finance

    SEC Form 3 filed by new insider Wiener Oliver

    3 - Chain Bridge I (0001845149) (Issuer)

    2/22/24 4:13:59 PM ET
    $CBRG
    Blank Checks
    Finance

    New insider Cb Co-Investment Llc claimed ownership of 575,665 units of Class A Ordinary Shares (SEC Form 3)

    3 - Chain Bridge I (0001845149) (Issuer)

    2/20/24 7:34:04 PM ET
    $CBRG
    Blank Checks
    Finance

    $CBRG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Phytanix Bio Publishes New Investor Deck Highlighting Strategic Vision and Growth Potential

    NEW YORK and SANTA BARBARA, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Phytanix Bio, a pioneering preclinical stage pharmaceutical company dedicated to the development of therapeutics based on cannabinoid and cannabinoid-like molecules, today announced the release of its new investor deck. The updated presentation provides an in-depth look at the company's strategic vision, scientific advancements, and growth potential as it progresses towards the development of next-generation cannabinoid medicines. The global cannabis pharmaceuticals market size was estimated at USD 3.4 billion in 2023 and is anticipated to grow at a CAGR of 53.3% from 2024 to 2030. The investor deck is now available on

    7/30/24 9:00:00 AM ET
    $CBRG
    Blank Checks
    Finance

    Chain Bridge I to Acquire Phytanix Bio, Creating a New Public Company Focused on Developing Next Generation Cannabinoid and Cannabinoid-like Medicines

    Phytanix Bio is a preclinical stage pharmaceutical company founded by former members and associates of GW Pharmaceuticals, holding exclusive cannabinoid and cannabinoid-like medicine intellectual property (IP)The transaction reflects a pre-deal valuation of $58 million for Phytanix Bio plus the assumption of $17 million of preferred stock and $4.4 million of short-term debt that will be exchanged for convertible preferred stock at deal closeThe business combination is expected to be completed in the fourth quarter of 2024, with the combined company to be listed on Nasdaq Capital Markets under the ticker "PHYX" NEW YORK and SANTA BARBARA, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Phytani

    7/22/24 5:45:34 PM ET
    $CBRG
    Blank Checks
    Finance

    Chain Bridge I Will Redeem Public Shares

    Chain Bridge I (the "Company") (NASDAQ:CBRGU, CBRG, CBRGW))), a special purpose acquisition company, today announced that it will redeem all of its outstanding Class A ordinary shares, par value $0.0001 (the "Public Shares"), effective as of the close of business on November 15, 2023, as the Company will not consummate an initial business combination within the time period required by its Amended and Restated Memorandum and Articles of Association (the "Articles"). The Company concluded it would be unable to meet its expectations for quality and long-term return potential by completing an initial business combination by November 15, 2023 (twenty-four months from the closing of the Company

    10/31/23 4:00:00 PM ET
    $CBRG
    Blank Checks
    Finance

    $CBRG
    SEC Filings

    View All

    SEC Form 10-Q filed by Chain Bridge I

    10-Q - Chain Bridge I (0001845149) (Filer)

    11/19/24 5:29:41 PM ET
    $CBRG
    Blank Checks
    Finance

    Chain Bridge I filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

    8-K - Chain Bridge I (0001845149) (Filer)

    11/19/24 6:05:29 AM ET
    $CBRG
    Blank Checks
    Finance

    SEC Form NT 10-Q filed by Chain Bridge I

    NT 10-Q - Chain Bridge I (0001845149) (Filer)

    11/14/24 5:29:34 PM ET
    $CBRG
    Blank Checks
    Finance

    $CBRG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Chain Bridge I

    SC 13G/A - Chain Bridge I (0001845149) (Subject)

    11/14/24 1:46:48 PM ET
    $CBRG
    Blank Checks
    Finance

    Amendment: SEC Form SC 13G/A filed by Chain Bridge I

    SC 13G/A - Chain Bridge I (0001845149) (Subject)

    11/14/24 12:49:36 PM ET
    $CBRG
    Blank Checks
    Finance

    Amendment: SEC Form SC 13G/A filed by Chain Bridge I

    SC 13G/A - Chain Bridge I (0001845149) (Subject)

    11/13/24 4:37:52 PM ET
    $CBRG
    Blank Checks
    Finance